Carolinas Wealth Consulting LLC Alnylam Pharmaceuticals, Inc. Transaction History
Carolinas Wealth Consulting LLC
- $557 Million
- Q4 2024
A detailed history of Carolinas Wealth Consulting LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Carolinas Wealth Consulting LLC holds 149 shares of ALNY stock, worth $48,393. This represents 0.01% of its overall portfolio holdings.
Number of Shares
149
Previous 159
6.29%
Holding current value
$48,393
Previous $43,000
18.6%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ALNY
# of Institutions
724Shares Held
111MCall Options Held
966KPut Options Held
853K-
Capital World Investors Los Angeles, CA16.7MShares$5.44 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$4.24 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$3.1 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$2.32 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.42MShares$1.43 Billion0.79% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $40B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...